Page last updated: 2024-09-05

deferasirox and Benign Neoplasms, Brain

deferasirox has been researched along with Benign Neoplasms, Brain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, EJ; Chueh, HW; Kim, JY; Koo, HH; Lee, SH; Sung, KW; Yoo, KH	1

Trials

1 trial(s) available for deferasirox and Benign Neoplasms, Brain

Article	Year
Iron chelation treatment with deferasirox prior to high-dose chemotherapy and autologous stem cell transplantation may reduce the risk of hepatic veno-occlusive disease in children with high-risk solid tumors. Pediatric blood & cancer, 2012, Volume: 58, Issue:3 Topics: Acute Kidney Injury; Benzoates; Brain Neoplasms; Child; Child, Preschool; Deferasirox; Erythrocyte Transfusion; Fanconi Syndrome; Female; Ferritins; Hepatic Veno-Occlusive Disease; Humans; Induction Chemotherapy; Infant; Iron Chelating Agents; Male; Neuroblastoma; Stem Cell Transplantation; Transplantation, Autologous; Triazoles	2012

Article

Year

Iron chelation treatment with deferasirox prior to high-dose chemotherapy and autologous stem cell transplantation may reduce the risk of hepatic veno-occlusive disease in children with high-risk solid tumors.

Pediatric blood & cancer, 2012, Volume: 58, Issue:3

Topics: Acute Kidney Injury; Benzoates; Brain Neoplasms; Child; Child, Preschool; Deferasirox; Erythrocyte Transfusion; Fanconi Syndrome; Female; Ferritins; Hepatic Veno-Occlusive Disease; Humans; Induction Chemotherapy; Infant; Iron Chelating Agents; Male; Neuroblastoma; Stem Cell Transplantation; Transplantation, Autologous; Triazoles

2012